TickerFactsScreenerDevelopers

Akebia Therapeutics, Inc. (AKBA) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $1.53M2017: $181.23M2018: $207.74M2019: $335.00M2020: $294.64M2021: $211.65M2022: $292.48M2023: $194.62M2024: $160.18M2025: $236.20M$236.20M
2016Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$236.20M+47.5%
2024$160.18M-17.7%
2023$194.62M-33.5%
2022$292.48M+38.2%
2021$211.65M-28.2%
2020$294.64M-12.0%
2019$335.00M+61.3%
2018$207.74M+14.6%
2017$181.23M+11706.3%
2016$1.53M—